# US 2009/0275579 A1 · 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0275579 A1
- Document ID: US20090275579A1
- Status: Published application
- Kind: A1
- Application number: 12/504,260
- Filed: 2009-07-16
- Published: 2009-11-05
- Earliest claimed: 2004-09-09
- Assignees: Sanofi-Aventis
- Inventors: Denis Brasseur; Claudine Serradeil-Le Gal; Gareth Shackleton
- Web page: https://patentgrep.com/patent/US20090275579A1

## CPC

- C07D 209/96: Spiro-condensed ring systems
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 1/08: for nausea, cinetosis or vertigo; Antiemetics
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 5/00: Drugs for disorders of the endocrine system
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61P 7/12: Antidiuretics, e.g. drugs for diabetes insipidus (ADH A61P5/10)
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 13/00: Drugs for disorders of the urinary system
- A61P 13/12: of the kidneys
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61P 15/10: for impotence
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 27/02: Ophthalmic agents
- A61P 27/06: Antiglaucoma agents or miotics
- A61P 27/12: for cataracts
- A61P 27/16: Otologicals
- A61P 35/00: Antineoplastic agents
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The subject of the present invention is a compound of formula (I): in the base, hydrate or solvate state, in the form of cis/trans isomers or of mixtures thereof, preparation and therapeutic use thereof.

## Claims

### Claim 1

A compound of formula (I):
in the base, hydrate or solvate state, in the form of cis/trans isomers or of mixtures thereof.

### Claim 2 (depends on 1)

A process for preparing a compound as claimed in claim 1, the process comprising reacting a morpholinone derivative of formula (III)
with a sulfonyl chloride of formula (II)

### Claim 3 (depends on 1)

A pharmaceutical composition, comprising at least one compound as claimed in claim 1, and at least one pharmaceutically acceptable excipient.

### Claim 4 (depends on 1)

A method of treating a patient suffering from, or subject to, a disease state selected from rinopathies and kidney dysfunction, abdominal ascites, central and peripheral nervous system conditions, cardiovascular system conditions, conditions of the endocrine and hepatic system, conditions of the renal sphere, conditions of the gastric, intestinal and pulmonary sphere, conditions in ophthalmology, and conditions in sexual behavior disorders, said method comprising the step of administering an effective amount of a compound according to claim 1 to said patient.

### Claim 5 (depends on 1)

A method of treating a patient suffering from, or subject to, a disease state resulting from vasopressin-dependent conditions or vasopressin secretion dysfunctions, said method comprising the step of administering an effective amount of a compound according to claim 1 to said patient.
